Showing results (11-20 of 298) with videos related to
Sort By:
Pageof 30
Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.Proceedings of the National Academy of Sciences of the United States of America|October 24, 2018
SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesisLucy C Young, Nicole Hartig, Isabel Boned Del Río, et al.Nature Structural & Molecular Biology|September 29, 2022
Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndromeDaniel A Bonsor, Patrick Alexander, Kelly Snead, et al.Journal of Molecular Medicine (Berlin, Germany)|March 11, 2016
K-Ras protein as a drug targetFrank McCormickCancer Biology & Therapy|September 26, 2003
Cancer-specific viruses and the development of ONYX-015Frank McCormickCancer Cell|January 18, 2020
Sticking it to KRAS: Covalent Inhibitors Enter the ClinicFrank McCormickBiological Chemistry|April 4, 2026
The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug designFrank McCormickExpert Opinion on Therapeutic Targets|January 7, 2015
The potential of targeting Ras proteins in lung cancerFrank McCormickAdvances in Cancer Research|February 1, 2022
A brief history of RAS and the RAS InitiativeFrank McCormickPageof 30